These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8296581)

  • 21. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.
    Sundblad C; Modigh K; Andersch B; Eriksson E
    Acta Psychiatr Scand; 1992 Jan; 85(1):39-47. PubMed ID: 1546547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual disorders in the course of clomipramine treatment: a report of three cases.
    Yassa R
    Can J Psychiatry; 1982 Mar; 27(2):148-9. PubMed ID: 7066846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.
    Leinonen E; Lepola U; Koponen H; Mehtonen OP; Rimon R
    Acta Psychiatr Scand; 1997 Dec; 96(6):497-504. PubMed ID: 9421348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin syndrome caused by olanzapine and clomipramine.
    Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Tortorella V; Varano M
    Minerva Anestesiol; 2008; 74(1-2):41-5. PubMed ID: 18004234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extreme suicidality following serotonin syndrome.
    Serfaty MA; McCluskey S; Eccleston D
    Br J Psychiatry; 1995 Sep; 167(3):410. PubMed ID: 7496659
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreased 5-HT-mediated prolactin release in major depression.
    Anderson IM; Ware CJ; da Roza Davis JM; Cowen PJ
    Br J Psychiatry; 1992 Mar; 160():372-8. PubMed ID: 1562864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Yawning and sexual excitation under clomipramine. Role of serotoninergic mechanisms. Apropos of 2 cases].
    Bertschy G; Vandel S; Sechter D; Bizouard P
    Encephale; 1991; 17(6):515-7. PubMed ID: 1806359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine production in major depressed patients before and after clomipramine treatment.
    Weizman R; Laor N; Podliszewski E; Notti I; Djaldetti M; Bessler H
    Biol Psychiatry; 1994 Jan; 35(1):42-7. PubMed ID: 8167203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clomipramine in the treatment of depressive syndrome: the results from the open study of Hydiphen].
    Myszka DM
    Psychiatr Pol; 1996; 30(6):1003-8. PubMed ID: 9132762
    [No Abstract]   [Full Text] [Related]  

  • 30. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.
    Petracca G; Tesón A; Chemerinski E; Leiguarda R; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 1996; 8(3):270-5. PubMed ID: 8854297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind controlled study on the clinical efficacy and safety of fluoxetine vs clomipramine in the treatment of major depressive disorders.
    Manna V; Martucci N; Agnoli A
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():81-8. PubMed ID: 2644342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial.
    Sallee FR; Vrindavanam NS; Deas-Nesmith D; Carson SW; Sethuraman G
    Am J Psychiatry; 1997 May; 154(5):668-73. PubMed ID: 9137123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin syndrome in a case of depression with various somatic symptoms: the difficulty in differential diagnosis.
    Terao T; Hikichi T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):295-6. PubMed ID: 16916568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Controlled study of treatment of residual depression by clomipramine versus placebo].
    Rouillon F; Markabi S; Febvre N; Phillips R; Vaillant J
    Encephale; 1994; 20(2):139-45. PubMed ID: 8050380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a relationship between response to total sleep deprivation and efficacy of clomipramine treatment in depressed patients?
    Höchli D; Riemann D; Zulley J; Berger M
    Acta Psychiatr Scand; 1986 Aug; 74(2):190-2. PubMed ID: 3776665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
    Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J
    Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of rare side effects of certain antidepressive drugs].
    Haenel T; Stöckli HR; Truog P
    Nervenarzt; 1995 Jan; 66(1):70-2. PubMed ID: 7885518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible serotonin syndrome following the combined administration of clomipramine and alprazolam.
    Cano-Muñoz JL; Montejo-Iglesias ML; Yañez-Saez RM; Gálvez-Borrero IM
    J Clin Psychiatry; 1995 Mar; 56(3):122. PubMed ID: 7883731
    [No Abstract]   [Full Text] [Related]  

  • 39. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J; Olivares J; Marcos T; Bulbena A; Menchón JM
    Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.